← All trials
NCT00213044
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2003
- Primary completion
- —
- Completion date
- Jun 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Population CouncilLead sponsor
- Chiang Rai District Health OfficeCollaborator
- Population CouncilOverall official - principal investigator
- National Center for HIV STD and TB PreventionCollaborator
- National Center for Infectious DiseasesCollaborator
- Chiangrai Prachanukroh HospitalCollaborator
- Government of ThailandCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.